Evaluation of the mechanism(s) of secretion of the conversion products of tenofovir disoproxil fumarate out of Caco-2 cells

J.F. Van Gelder; S. Deferme; Nico Vermeulen; Raf Mols; Guy Van den Mooter; De Clercq Erik; Renaat Kinget; Patrick Augustijns

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2001

Evidence for multidrug resistance-associated proteins related efflux of the metabolites of tenofovir disoproxil fumarate in Caco-2 monolayers

J. Van Gelder, S. Deferme, Nico Vermeulen, Raf Mols, Guy Van den Mooter, De Clercq Erik, Lieve Naesens, Renaat Kinget, Patrick Augustijns

Article2016

Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)

De Clercq Erik

Article2018

Pharmacokinetics of Oral Tenofovir Disoproxil Fumarate in Pregnancy and Lactation: A Systematic Review

Marieke Bierhoff, Elise J. Smolders, Joel Tärning, David M. Burger, René Spijker, Marcus J. Rijken, Chaisiri Angkurawaranon, Rose McGready, Sir Nicholas White, François Nosten, Michèle van Vugt

Antiviral Therapy

Article2005

Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites

Roel Mallants, K. Van Oosterwyck, L. Van Vaeck, Raf Mols, De Clercq Erik, Patrick Augustijns

Article2002

Intestinal Absorption Enhancement of the Ester Prodrug Tenofovir Disoproxil Fumarate through Modulation of the Biochemical Barrier by Defined Ester Mixtures

J. Van Gelder, S. Deferme, Lieve Naesens, De Clercq Erik, Guy Van den Mooter, Renaat Kinget, Patrick Augustijns